Canna Law Blog
AUGUST 25, 2020
The outfit actually began in response to the Drug Enforcement Administration (DEA) scheduling MDMA, more or less, which happened on an “emergency” basis in 1985 (you can view MAPS’ impressive archive and play-by-play on all of that here ). The drug caught DEA’s attention when recreational use proliferated. Just kidding!
Canna Law Blog
AUGUST 25, 2020
The outfit actually began in response to the Drug Enforcement Administration (DEA) scheduling MDMA, more or less, which happened on an “emergency” basis in 1985 (you can view MAPS’ impressive archive and play-by-play on all of that here ). The drug caught DEA’s attention when recreational use proliferated. Just kidding!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PrestoDoctor
JULY 16, 2019
The DPF changed its name in 2000 when it merged with the Ethan Nadelmann’s Lindesmith Center. The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress. Zeese had previously directed NORML in the early 80s.
PrestoDoctor
JULY 16, 2019
The DPF changed its name in 2000 when it merged with the Ethan Nadelmann’s Lindesmith Center. The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress. Zeese had previously directed NORML in the early 80s.
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.
Cannabis Law Report
SEPTEMBER 19, 2019
Here are three of the most pressing matters that might give Congress absolutely no choice but to surrender to marijuana legalization in the interest of public health and safety. . . “ It is already causing a slew of problems in states across the nation. Reason #1: Police confused on how to distinguish the difference between?
Cannabis Law Report
MARCH 25, 2019
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 18, 2000 , 114 Stat. 25, 2000 , 114 Stat. 2(a), (b)(1), Oct. 13, 1996 , 110 Stat. 3807 ; Pub.
Expert insights. Personalized for you.
88 
Let's personalize your content